Influence of tyrosine kinase inhibitors and everolimus on TGFβ1 and TGF-β receptor 2 in squamous cell carcinoma cells
Background/Aim: Transforming growth factor-β (TGF-β) plays a significant role in the formation of different cancer subtypes. There is evidence that TGF-β pathways promote cancerogenic cell characteristics but also have tumor-suppressor capabilities. The tyrosine kinase inhibitors nilotinib, dasatini...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
August 2024
|
| In: |
Anticancer research
Year: 2024, Jahrgang: 44, Heft: 8, Pages: 3287-3294 |
| ISSN: | 1791-7530 |
| DOI: | 10.21873/anticanres.17147 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.21873/anticanres.17147 Verlag, kostenfrei, Volltext: https://ar.iiarjournals.org/content/44/8/3287 
|
| Verfasserangaben: | Lena Huber, Manuel Thomas Knüttel, Benedikt Kramer, Lena Zaubitzer, Anne Lammert, Claudia Scherl, Nicole Rotter and Daniel Häussler |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1918444145 | ||
| 003 | DE-627 | ||
| 005 | 20250716233618.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250225s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21873/anticanres.17147 |2 doi | |
| 035 | |a (DE-627)1918444145 | ||
| 035 | |a (DE-599)KXP1918444145 | ||
| 035 | |a (OCoLC)1528019485 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Huber, Lena |d 1989- |e VerfasserIn |0 (DE-588)1209606402 |0 (DE-627)1697276873 |4 aut | |
| 245 | 1 | 0 | |a Influence of tyrosine kinase inhibitors and everolimus on TGFβ1 and TGF-β receptor 2 in squamous cell carcinoma cells |c Lena Huber, Manuel Thomas Knüttel, Benedikt Kramer, Lena Zaubitzer, Anne Lammert, Claudia Scherl, Nicole Rotter and Daniel Häussler |
| 246 | 3 | 3 | |a Influence of tyrosine kinase inhibitors and everolimus on TGF beta 1 and TGF-beta receptor 2 in squamous cell carcinoma cells |
| 264 | 1 | |c August 2024 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 26. Juli 2024 | ||
| 500 | |a Gesehen am 25.02.2025 | ||
| 520 | |a Background/Aim: Transforming growth factor-β (TGF-β) plays a significant role in the formation of different cancer subtypes. There is evidence that TGF-β pathways promote cancerogenic cell characteristics but also have tumor-suppressor capabilities. The tyrosine kinase inhibitors nilotinib, dasatinib, erlotinib, gefitinib, and everolimus are approved as targeted therapies for several tumor entities, including head and neck squamous cell carcinoma (HNSCC). This study aimed to investigate the effects of these substances on the expression levels of TGFβ1 and TGF-β receptor type 2 (TGFβR2) in HPV-negative and HPV-positive SCC cell cultures. Materials and Methods: Expression patterns of TGFβ1 and TGFβR2 were determined using enzyme-linked immunosorbent assay (ELISA) in three HNSCC cell lines (i.e., HNSCC-11A, HNSCC-14C, and CERV196). These cells were incubated with nilotinib, dasatinib, erlotinib, gefitinib, and everolimus (20 μmol/l) and compared to a chemonaive control. An assessment of concentration levels was conducted after 24, 48, 72, and 96 h of treatment. Results: Statistically significant changes in the expression levels of TGFβ1 and TGFβR2 were found in all tested cell cultures (p<0.05) compared to the negative control. An increase in TGFβ-R2 expression was detected after treatment with most of the tested tyrosine kinase inhibitors, whereas a reduction in TGFβ1 was observed. The addition of everolimus had the opposite effect on both TGFβR2 and TGF-B1- expression. Conclusion: Expression of TGFβ1 and TGFβR2 was detected in all cultured HNSCC cell lines. Nilotinib, dasatinib, erlotinib, gefitinib, and everolimus had an impact on the expression levels of TGFβ1 and TGFβR2 in vitro. | ||
| 650 | 4 | |a Head and neck squamous cell carcinoma (HNSCC) | |
| 650 | 4 | |a tyrosine kinase inhibitors | |
| 700 | 1 | |a Knüttel, Manuel Thomas |d 1995- |e VerfasserIn |0 (DE-588)1311438882 |0 (DE-627)1871452422 |4 aut | |
| 700 | 1 | |a Kramer, Benedikt |d 1985- |e VerfasserIn |0 (DE-588)1067455698 |0 (DE-627)818750677 |0 (DE-576)42666048X |4 aut | |
| 700 | 1 | |a Zaubitzer, Lena |d 1990- |e VerfasserIn |0 (DE-588)1201660882 |0 (DE-627)1685739520 |4 aut | |
| 700 | 1 | |a Lammert, Anne |d 1983- |e VerfasserIn |0 (DE-588)137533365 |0 (DE-627)695845284 |0 (DE-576)303406097 |4 aut | |
| 700 | 1 | |a Scherl, Claudia |d 1977- |e VerfasserIn |0 (DE-588)132069555 |0 (DE-627)517465426 |0 (DE-576)298927101 |4 aut | |
| 700 | 1 | |a Rotter, Nicole |d 1970- |e VerfasserIn |0 (DE-588)118085638 |0 (DE-627)079235514 |0 (DE-576)178653888 |4 aut | |
| 700 | 1 | |a Häussler, Daniel |d 1988- |e VerfasserIn |0 (DE-588)1103597280 |0 (DE-627)861404394 |0 (DE-576)470699612 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anticancer research |d Kapandriti, Attiki, Greece : International Institute of Anticancer Research, 2004 |g 44(2024), 8 vom: Aug., Seite 3287-3294 |h Online-Ressource |w (DE-627)387478493 |w (DE-600)2145376-7 |w (DE-576)358408717 |x 1791-7530 |7 nnas |a Influence of tyrosine kinase inhibitors and everolimus on TGFβ1 and TGF-β receptor 2 in squamous cell carcinoma cells |
| 773 | 1 | 8 | |g volume:44 |g year:2024 |g number:8 |g month:08 |g pages:3287-3294 |g extent:8 |a Influence of tyrosine kinase inhibitors and everolimus on TGFβ1 and TGF-β receptor 2 in squamous cell carcinoma cells |
| 856 | 4 | 0 | |u https://doi.org/10.21873/anticanres.17147 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://ar.iiarjournals.org/content/44/8/3287 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250225 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 1103597280 |a Häussler, Daniel |m 1103597280:Häussler, Daniel |d 60000 |d 62100 |e 60000PH1103597280 |e 62100PH1103597280 |k 0/60000/ |k 1/60000/62100/ |p 8 |y j | ||
| 998 | |g 118085638 |a Rotter, Nicole |m 118085638:Rotter, Nicole |d 60000 |d 62100 |e 60000PR118085638 |e 62100PR118085638 |k 0/60000/ |k 1/60000/62100/ |p 7 | ||
| 998 | |g 132069555 |a Scherl, Claudia |m 132069555:Scherl, Claudia |d 60000 |d 62100 |e 60000PS132069555 |e 62100PS132069555 |k 0/60000/ |k 1/60000/62100/ |p 6 | ||
| 998 | |g 137533365 |a Lammert, Anne |m 137533365:Lammert, Anne |d 60000 |d 62100 |e 60000PL137533365 |e 62100PL137533365 |k 0/60000/ |k 1/60000/62100/ |p 5 | ||
| 998 | |g 1201660882 |a Zaubitzer, Lena |m 1201660882:Zaubitzer, Lena |d 60000 |e 60000PZ1201660882 |k 0/60000/ |p 4 | ||
| 998 | |g 1067455698 |a Kramer, Benedikt |m 1067455698:Kramer, Benedikt |d 60000 |d 62100 |e 60000PK1067455698 |e 62100PK1067455698 |k 0/60000/ |k 1/60000/62100/ |p 3 | ||
| 998 | |g 1311438882 |a Knüttel, Manuel Thomas |m 1311438882:Knüttel, Manuel Thomas |d 60000 |e 60000PK1311438882 |k 0/60000/ |p 2 | ||
| 998 | |g 1209606402 |a Huber, Lena |m 1209606402:Huber, Lena |d 60000 |e 60000PH1209606402 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1918444145 |e 4671856530 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1918444145","id":{"doi":["10.21873/anticanres.17147"],"eki":["1918444145"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"August 2024","dateIssuedKey":"2024"}],"name":{"displayForm":["Lena Huber, Manuel Thomas Knüttel, Benedikt Kramer, Lena Zaubitzer, Anne Lammert, Claudia Scherl, Nicole Rotter and Daniel Häussler"]},"note":["Online veröffentlicht: 26. Juli 2024","Gesehen am 25.02.2025"],"titleAlt":[{"title":"Influence of tyrosine kinase inhibitors and everolimus on TGF beta 1 and TGF-beta receptor 2 in squamous cell carcinoma cells"}],"language":["eng"],"person":[{"given":"Lena","display":"Huber, Lena","family":"Huber","role":"aut"},{"given":"Manuel Thomas","role":"aut","family":"Knüttel","display":"Knüttel, Manuel Thomas"},{"display":"Kramer, Benedikt","family":"Kramer","role":"aut","given":"Benedikt"},{"display":"Zaubitzer, Lena","family":"Zaubitzer","role":"aut","given":"Lena"},{"role":"aut","family":"Lammert","display":"Lammert, Anne","given":"Anne"},{"given":"Claudia","family":"Scherl","role":"aut","display":"Scherl, Claudia"},{"display":"Rotter, Nicole","role":"aut","family":"Rotter","given":"Nicole"},{"display":"Häussler, Daniel","family":"Häussler","role":"aut","given":"Daniel"}],"relHost":[{"part":{"extent":"8","pages":"3287-3294","year":"2024","issue":"8","text":"44(2024), 8 vom: Aug., Seite 3287-3294","volume":"44"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Anticancer research","title_sort":"Anticancer research","subtitle":"international journal of cancer research and treatment"}],"disp":"Influence of tyrosine kinase inhibitors and everolimus on TGFβ1 and TGF-β receptor 2 in squamous cell carcinoma cellsAnticancer research","name":{"displayForm":["International Institute of Anticancer Research"]},"origin":[{"publisherPlace":"Kapandriti, Attiki, Greece","dateIssuedKey":"2004","dateIssuedDisp":"2004-","publisher":"International Institute of Anticancer Research"}],"id":{"eki":["387478493"],"zdb":["2145376-7"],"issn":["1791-7530"]},"recId":"387478493","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 26.02.13"],"pubHistory":["Nachgewiesen 24.2004 -"],"language":["eng"]}],"physDesc":[{"extent":"8 S."}],"title":[{"title":"Influence of tyrosine kinase inhibitors and everolimus on TGFβ1 and TGF-β receptor 2 in squamous cell carcinoma cells","title_sort":"Influence of tyrosine kinase inhibitors and everolimus on TGFβ1 and TGF-β receptor 2 in squamous cell carcinoma cells"}]} | ||
| SRT | |a HUBERLENAKINFLUENCEO2024 | ||